Martijn van der Heijden

20062024

Research activity per year

Network

Laura Mertens

Person: Academic

Rob Verhoeven

Person: Academic

Jorg Oddens

Person: Academic

Theo de Reijke

Person: Academic

Peter Meijer

Person: Academic

Jeroen van Dorp

  • Netherlands Cancer Institute

External person

Conchita Vens

  • Department of Pathology

External person

Ronald de Wit

  • Erasmus Universiteit Rotterdam

External person

B. Szabados

  • Queen Mary University of London

External person

Simon Horenblas

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

Bas W.G. van Rhijn

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital
  • European Association of Urology
  • University of Toronto
  • University of Regensburg
  • Netherlands Cancer Institute/Antoni van Leeuwenhoek Huis
  • Erasmus Universiteit Rotterdam
  • Princess Margaret Hospital University of Toronto
  • Franciscus Gasthuis & Vlietland
  • University Health Network University of Toronto
  • Astellas Pharma Inc.

External person

Alberto Gil-Jimenez

  • Netherlands Cancer Institute
  • Oncode Institute, Utrecht, The Netherlands

External person

Paul B.M. Essers

  • Department of Pathology

External person

Sarah M. H. Einerhand

  • Netherlands Cancer Institute

External person

D. D. G. C. Peters

  • Netherlands Cancer Institute

External person

Sebastian Sanduleanu

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

Oscar Roberto Brouwer

  • Netherlands Cancer Institute

External person

Harry Bartelink

  • Department of Pathology

External person

Linde Braaf

  • Netherlands Cancer Institute

External person

R.H. De Roest

  • Vrije Universiteit Amsterdam
  • VU University Medical Center
  • VU University

External person

J. M. de Feijter

  • Netherlands Cancer Institute

External person

F.J.P. Hoebers

  • Forensic Psychiatric Centre De Rooyse Wissel and Maastricht University
  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

Eva Eline Schaake

  • Netherlands Cancer Institute

External person

Jeantine M. de Feijter

  • Netherlands Cancer Institute

External person

M. Linch

  • Queen Mary University of London

External person

Katrin Hippe

  • University of Regensburg

External person

Geert J. L. H. van Leenders

  • Erasmus MC Cancer Institute
  • Radboud University Nijmegen
  • Erasmus Universiteit Rotterdam

External person

Martijn P. J. Lolkema

  • Erasmus Universiteit Rotterdam

External person

Hielke M. de Vries

  • Netherlands Cancer Institute

External person

Maureen J. B. Aarts

  • Maxima Medical Centre

External person

A. Ravaud

  • Hôpital Saint-André
  • French Society of Dermatology and Department of Dermatology, France

External person

M. Verheij

  • Department of Pathology
  • Donders Institute
  • Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital

External person

Philippe Lambin

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

Wolfgang Otto

  • University of Regensburg

External person

Roman Mayr

  • University of Regensburg

External person

B. P. Valderrama

  • Hospital Universitario Virgen del Rocio

External person

Henk G. van der Poel

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

Simon Keek

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

Alberto Contreras-Sanz

  • University of British Columbia

External person

Arjun V. Balar

  • New York University

External person

R. Bryan Rumble

  • American Society of Clinical Oncology

External person

Jean Hoffman-Censits

  • Johns Hopkins University

External person

Sabine de Ducla

  • F. Hoffmann-La Roche AG

External person

Theo H. van der Kwast

  • Erasmus MC Cancer Institute
  • University Health Network
  • University of Toronto

External person

Theodora M. Ripping

  • Netherlands Comprehensive Cancer Organisation
  • Netherlands Comprehensive Cancer Organization

External person

Benjamin Ayres

  • St. George's University of London

External person

Simon Fear

  • F. Hoffmann-La Roche AG

External person

Vasileios I. Sakalis

  • Agios Pavlos General Hospital

External person

Sasja F. Mulder

  • Radboud University Nijmegen

External person

Pedro Oliveira

  • The Christie NHS Foundation Trust

External person

B. P. Wijsman

  • Elisabeth-Tweesteden Ziekenhuis

External person

Markus Eckstein

  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Joost L. Boormans

  • Erasmus Universiteit Rotterdam

External person

Yanish Soorojebally

  • Sorbonne Université

External person

Monique C. de Jong

  • Department of Pathology

External person

Michael A. S. Jewett

  • University Health Network
  • University of Toronto
  • Princess Margaret Hospital University of Toronto

External person

Isabella Greco

  • University of Florence

External person

Frederik Wesseling

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

A. A. van der Veldt

  • Erasmus Universiteit Rotterdam

External person

Antoine G van der Heijden

  • Radboud University Nijmegen

External person

Debbie G. J. Robbrecht

  • Erasmus Universiteit Rotterdam

External person

L. M. C. van Hoogstraten

  • Radboud University Nijmegen

External person

Greg Jones

  • Inivata Ltd.

External person

Chantal F. Stockem

  • Netherlands Cancer Institute

External person

J. L. Boormans

  • Erasmus Universiteit Rotterdam

External person

Curtis A. Pettaway

  • University of Texas MD Anderson Cancer Center

External person

Oscar R. Brouwer

  • Netherlands Cancer Institute

External person

Charlotte Tyson

  • Queen Mary University of London

External person

Riccardo Campi

  • Azienda Ospedaliera Careggi

External person

Ralph Leijenaar

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

O. Hamming-Vrieze

  • Department of Pathology
  • Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital

External person

Yoni Lubeck

  • Netherlands Cancer Institute

External person

Alexandre R. Zlotta

  • University of Toronto
  • University Health Network
  • Princess Margaret Hospital University of Toronto

External person

M. Franckena

  • Erasmus MC

External person

Sophie Hackinger

  • Wellcome Sanger Institute

External person

Julie Pavlova

  • F. Hoffmann-La Roche AG

External person

Robert A. Huddart

  • Royal Marsden NHS Foundation Trust

External person

Cheno Abas

  • Erasmus Universiteit Rotterdam

External person

Simone Bertz

  • Hospital St. John of Lord
  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Bernd Wullich

  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Ton N. Schumacher

  • Hospital Pharmacy

External person

Lance C. Pagliaro

  • Mayo Clinic Rochester, MN

External person

Antonios Daletzakis

  • Netherlands Cancer Institute

External person

Yann Neuzillet

  • Antoni Van Leeuwenhoek Hospital

External person

K. Scheckenbach

  • Heinrich Heine University Duesseldorf
  • University Hospital Duesseldorf

External person

Arie Parnham

  • The Christie NHS Foundation Trust

External person

Floris Jop Pos

  • Netherlands Cancer Institute

External person

Herney A. Garcia-Perdomo

  • Universidad del Valle

External person

Joep van Roermund

  • Maastricht University

External person

Chris Protzel

  • Fresenius AG

External person

Arndt Hartmann

  • Hospital St. John of Lord
  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Axel S. Merseburger

  • University of Lübeck

External person

Giovanni Marsico

  • Inivata Ltd.

External person

Stefanie Götz

  • University of Regensburg

External person

Charlaine van Steenis

  • Netherlands Cancer Institute

External person

Damien Pouessel

  • Sorbonne Université
  • Université Fédérale Toulouse Midi-Pyrénées

External person

Marc Dall'Era

  • University of California, Davis

External person

K. E. van der Vos

  • Netherlands Cancer Institute

External person

Katja K.H. Aben

  • Radboud University Nijmegen
  • Netherlands Comprehensive Cancer Organisation
  • Department of Obstetrics and Gynaecology
  • Comprehensive Cancer Centre the Netherlands
  • IKNL
  • Clinical Research Department
  • Netherlands Comprehensive Cancer Organisation
  • Research and Development Department
  • Integraal Kankercentrum Nederland (IKNL)
  • Netherlands Comprehensive Cancer Organization

External person

Lambertus A. L. M. Kiemeney

  • Department of Obstetrics and Gynaecology
  • Radboud University Nijmegen

External person

Łukasz Zapala

  • Medical University of Warsaw

External person

Yves Allory

  • Sorbonne Université
  • Institut Curie

External person

T. J. Smilde

  • Jeroen Bosch Ziekenhuis

External person

W. Zwart

  • Netherlands Cancer Institute
  • Eindhoven University of Technology

External person

Diego F. Sánchez Martínez

  • Universidad Nacional De Asunción

External person

Mithun Kailavasan

  • Nottingham University Hospitals NHS Trust

External person

Kirsten McLay

  • Inivata Ltd.

External person

Joyce Sanders

  • Antoni Van Leeuwenhoek Hospital
  • Netherlands Cancer Institute

External person

J. Alberto Nakauma-González

  • Erasmus Universiteit Rotterdam

External person

Robert Stoehr

  • Hospital St. John of Lord
  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Lenka Barreto

  • University Hospital Nitra

External person

Tiago Antunes-Lopes

  • Centro Hospitalar Universitário de São João

External person

Peter J. Bostrom

  • University of Toronto
  • University of Turku
  • Princess Margaret Hospital University of Toronto

External person

Nanor Sirab

  • Sorbonne Université

External person

J. Alfred Witjes

  • Department of Obstetrics and Gynaecology
  • Radboudumc
  • Radboud University Nijmegen

External person

Maud Rijnders

  • Erasmus Universiteit Rotterdam

External person

Tauanne Amarante

  • Inivata Ltd.

External person

François Radvanyi

  • Sorbonne Université
  • Institut Curie
  • Erasmus Universiteit Rotterdam

External person

R. Seiler

  • University of British Columbia

External person

B. Winters

  • University of British Columbia

External person

Daniela Purcea

  • Harvard University

External person

Ashwin Sachdeva

  • Newcastle upon Tyne Hospitals NHS Foundation Trust

External person

Luke A. McGuinness

  • Population Health Sciences, Bristol, United Kingdom

External person

Jill B. de Vis

  • University Medical Center Utrecht
  • Johns Hopkins University
  • Utrecht University
  • Netherlands Cancer Institute

External person

François Audenet

  • Hôpital européen Georges Pompidou

External person

Timo M. Deist

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

L. Licitra

  • Università degli Studi di Milano Statale
  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

External person

Eva E. Schaake

  • Netherlands Cancer Institute

External person

John N. Waldron

  • University Health Network

External person

Joost L. Boormans

  • Erasmus MC Cancer Institute
  • Erasmus Universiteit Rotterdam

External person

Floris J. Pos

  • Netherlands Cancer Institute
  • Antoni Van Leeuwenhoek Hospital

External person

Virginie Marty

  • Institut Gustave Roussy
  • University of Paris

External person

A. Rogier Donders

  • Radboud University Medical Center

External person

Thibault Raoult

  • Institut Gustave Roussy

External person

Tahlita C. M. Zuiverloon

  • Erasmus MC Cancer Institute
  • Erasmus Universiteit Rotterdam

External person

Mark N. Stein

  • Columbia University

External person

Regula Deurloo

  • F. Hoffmann-La Roche AG

External person

Francisco X. Real

  • Instituto de Salud Carlos III
  • Pompeu Fabra University

External person

Núria Malats

  • Instituto de Salud Carlos III
  • Municipal Institute for Medical Research Hospital del Mar

External person

Thi Dan Linh Nguyen-Kim

  • Antoni Van Leeuwenhoek Hospital
  • Maastricht University
  • University Hospital Zurich

External person

Se Hoon Park

  • University School of Medicine, 06351 Seoul, South Korea

External person

Nanor Sirab

  • Université PSL

External person

Peter J. Bostrom

  • University Health Network
  • University of Turku

External person

Maria Carmen Mir

  • Cleveland Clinic Foundation
  • Instituto Valenciano de Oncologia

External person

Nicole N. Davarpanah

  • Genentech Incorporated

External person

Juanita M. Crook

  • University of British Columbia

External person

Maximilian Burger

  • University of Regensburg
  • European Association of Urology

External person

Craig Gedye

  • Calvary Mater Newcastle

External person

E. Nevedomskaya

  • Netherlands Cancer Institute

External person

Eva M. Compérat

  • Guidelines Office, European Association of Urology, Arnhem, The Netherlands
  • Sorbonne Université

External person

Leonardo Lordello

  • Institut Gustave Roussy
  • University of Paris

External person

Jan Unkelbach

  • University Hospital of Psychiatry

External person

Teresa M. Tareco Bucho

  • Antoni Van Leeuwenhoek Hospital
  • Maastricht University

External person

Hesham M. Elhalawani

  • The University of Texas MD Anderson Cancer Center

External person

Rossana Bussani

  • University of Trieste

External person

Gabriel Haddad

  • MEPHI - Microbes, Evolution, Phylogénie et Infections

External person

Anne-Gaëlle Goubet

  • Institut Gustave Roussy
  • Université Paris-Saclay
  • University of Paris

External person

V. W. M. van Hinsbergh

  • Vrije Universiteit Amsterdam

External person

Andrea Necchi

  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano

External person

Nadège Cayet

  • Institut Pasteur Paris

External person

Zuhir Bodalal

  • Antoni Van Leeuwenhoek Hospital
  • Maastricht University

External person

Ivo Gomperts Boneca

  • Université Paris Cité

External person

E. A. Gibb

  • University of British Columbia

External person

Takahiro Kojima

  • University of Tsukuba

External person

Sara Balduzzi

  • Netherlands Cancer Institute

External person

Caroline McKay

  • Astellas Pharma Inc.

External person

Jonathan L. Wrighta

  • Fred Hutchinson Cancer Research Center

External person

Anna M. Leliveld

  • University of Groningen

External person

Henry C. Woodruff

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

Samir Barakat

  • GROW School for Oncology and Developmental Biology – University of Maastricht

External person

Charlotte van Rooijen

  • Netherlands Cancer Institute

External person

Matthias Guckenberger

  • University Hospital of Psychiatry

External person

Giuseppina Calareso

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

External person

Ellen C Zwarthoff

  • Erasmus Universiteit Rotterdam

External person

Mehmet A. Bilen

  • Emory University

External person

Romain Daillere

  • Institut Gustave Roussy

External person

Howard Gurney

  • University of Sydney
  • Westmead Hospital

External person

M. M. Takhar

  • University of British Columbia

External person

Joyce Sanders

  • Netherlands Cancer Institute

External person

Onno W. Kranenburg

  • University Medical Centre Utrecht

External person

Eiji Kikuchi

  • St. Marianna University School of Medicine

External person

L. M. C. van Hoogstraten

  • Radboud University Medical Center
  • Netherlands Comprehensive Cancer Organisation

External person

Joyce Sanders

  • Department of Pathology

External person

Kevin Mulder

  • Institut Gustave Roussy
  • Université Paris-Saclay
  • University of Paris

External person

Ugo de Giorgi

  • Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

External person

E.K. Vos

  • Netherlands Cancer Institute

External person

Wei Lin

  • Nektar

External person

Sandra van Wilpe

  • Netherlands Cancer Institute

External person

Henry C. Woodruff

  • Maastricht University

External person

A. B. J. Groeneveld

  • Vrije Universiteit Amsterdam

External person

Tito Poli

  • University of Parma
  • University Hospital of Parma

External person

Clifton D. Fuller

  • The University of Texas MD Anderson Cancer Center

External person

Cassandra Thelemaque

  • Institut Gustave Roussy
  • University of Paris

External person

Janneke E. W. Walraven

  • Radboud University Nijmegen
  • Netherlands Comprehensive Cancer Organisation

External person

Lisa Derosa

  • Institut Gustave Roussy
  • Université Paris-Saclay
  • University of Paris

External person

Daniel M. Geynisman

  • Fox Chase Cancer Center

External person

Maxime Descartes Mbogning-Fonkou

  • Institut Gustave Roussy
  • University of Paris

External person

T. Poli

  • University of Parma

External person

Zsolt Hepp

  • Seagen, Bothell, WA, USA

External person

Federico Nasroulah

  • Bradford Hill Clinical Research Center

External person

Michael R. Harrison

  • Duke University

External person

Inge M. van Oort

  • Radboud University Nijmegen

External person